PYXS logo

Pyxis Oncology, Inc. (PYXS)

Profile

Full Name

Pyxis Oncology, Inc.

Ticker

NASDAQ: PYXS

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

October 8, 2021

Indexes

Not included

Website

https://www.pyxisoncology.com

Employees

44

Key Details

Price

$2.57(14.22%)

Market Cap

$159.39M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$16.15M(100.00% YoY)

Annual EPS

-$1.32(28.45% YoY)

PE Ratio

-

Next earnings date

Nov 11, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $2.57
    PYXS price is $2.57

    30-Day Relative Volume

    1.42
    PYXS 30-day relative volume is 1.42

    Price Performance

    Price Most Recent Change

    +14.22%
    PYXS price was up +14.22% on Oct 3, 2025

    Price YTD Change

    +64.74%
    PYXS price is up +64.74% since January 1st

    Price 1-Year Change

    -27.4%
    PYXS price is down -27.4% year-on-year

    Price 3-Year Change

    +33.85%
    PYXS price is up +33.85% over the past 3 years

    Price Range

    Price All-Time High

    $19.00
    PYXS price is currently -86.47% below its historical high of $19.00

    Price 3-Year Low

    $0.83
    PYXS price is currently +208.52% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market Cap

    $159.39M
    PYXS market cap is $159.39 million

    Market Cap 3-Year Change

    +136.53%
    PYXS market cap is up +136.53% over the past 3 years

    Market Cap All-Time High

    $446.61M
    PYXS market cap is currently -64.31% below its historical high of $446.61 million

    Market Cap Sector Percentile

    46.3%
    PYXS market cap is higher than 46.3% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +4.32%
    PYXS shares outstanding is up +4.32% year-on-year

    Shares Outstanding 3-Year Change

    +90.31%
    PYXS shares outstanding is up +90.31% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.28
    PYXS beta is 1.28

    200-day SMA

    $1.33
    PYXS price is currently +92.70% above its 200-day simple moving average

    50-day SMA

    $1.59
    PYXS price is currently +61.85% above its 50-day simple moving average

    14-Day RSI

    76.76
    PYXS 14-day relative strength index is 76.76

    Volume

    1.42
    PYXS 30-day relative volume is 1.42

    ATR

    $0.17
    PYXS average true range is $0.17

    10-day Historical Volatility

    84.34%
    PYXS 10-day historical volatility is 84.34%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $16.15M
    PYXS annual revenue is $16.15 million

    Revenue Analysts Estimate

    $2.01M
    PYXS annual revenue is currently +703.86% higher than the consensus analysts' forecast

    Revenue 1-Year Change

    +100%
    PYXS annual revenue is up +100% year-on-year

    Revenue Sector Percentile

    51.63%
    PYXS annual revenue is higher than 51.63% of companies in Healthcare sector

    EPS

    EPS

    -$1.32
    PYXS annual earnings per share is -$1.32

    EPS Analysts Estimate

    -$1.28
    PYXS annual earnings per share is currently +3.37% higher than the consensus analysts' forecast

    EPS 1-Year Change

    +28.45%
    PYXS annual earnings per share is up +28.45% year-on-year

    EPS Sector Percentile

    48.35%
    PYXS annual earnings per share is higher than 48.35% of companies in Healthcare sector

    Profit

    Gross Profit

    $12.69M
    PYXS annual gross profit is $12.69 million

    Gross Margin

    78.59%
    PYXS annual gross profit margin is 78.59%

    Operating Profit

    -$68.50M
    PYXS annual operating income is -$68.50 million

    Operating Margin

    -424.23%
    PYXS annual operating profit margin is -424.23%

    Net Income

    -$77.33M
    PYXS annual net profit is -$77.33 million

    Net Margin

    -478.95%
    PYXS annual net profit margin is -478.95%

    Expenses

    Total Expenses

    $84.64M
    PYXS annual total expenses is $84.64 million

    Operating Expenses

    $84.17M
    PYXS annual total operating expenses is $84.17 million

    Cost Of Goods Sold

    $3.46M
    PYXS annual cost of goods sold is $3.46 million

    Selling, General & Administrative Expenses

    $25.42M
    PYXS annual SG&A is $25.42 million

    Depreciation & Amortization

    $2.98M
    PYXS annual D&A is $2.98 million

    Interest Expense

    $0.00
    PYXS annual interest expense is $0.00

    Income Tax

    -$2.16M
    PYXS annual income tax is -$2.16 million

    EBIT & EBITDA

    EBIT

    -$68.50M
    PYXS annual earnings before interest & taxes is -$68.50 million

    EBITDA

    -$65.51M
    PYXS annual EBITDA is -$65.51 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total Assets

    $157.18M
    PYXS annual total assets is $157.18 million

    Non Current Assets

    $24.74M
    PYXS annual long term assets is $24.74 million

    Current Assets

    $132.44M
    PYXS annual total current assets is $132.44 million

    Cash and Cash Equivalents

    $19.47M
    PYXS annual cash & cash equivalents is $19.47 million

    Accounts Receivable

    -
    PYXS annual accounts receivable value is unknown

    Inventory

    $0.00
    PYXS annual inventory is $0.00

    Liabilities

    Total Liabilities

    $36.43M
    PYXS annual total liabilities is $36.43 million

    Long Term Liabilities

    $18.75M
    PYXS annual total long term liabilities is $18.75 million

    Current Liabilities

    $17.68M
    PYXS annual current liabilities is $17.68 million

    Accounts Payable

    $4.86M
    PYXS annual accounts payable is $4.86 million

    Debt

    Total Debt

    $20.20M
    PYXS annual total debt is $20.20 million

    Total Debt 1-Year Change

    -5.3%
    PYXS annual total debt is down -5.3% year-on-year

    Long Term Debt

    $18.75M
    PYXS annual long term debt is $18.75 million

    Short Term Debt

    $1.45M
    PYXS annual short term debt is $1.45 million

    Equity & Capital

    Shareholders Equity

    $120.75M
    PYXS annual stockholders equity is $120.75 million

    Book Value

    $120.75M
    PYXS annual book value is $120.75 million

    Retained Earnings

    -$363.56M
    PYXS annual retained earnings is -$363.56 million

    Working Capital

    $114.76M
    PYXS annual working capital is $114.76 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash From Operations

    -$57.67M
    PYXS annual cash from operations is -$57.67 million

    Cash From Operations 1-Year Change

    +18.44%
    PYXS annual cash from operations is up +18.44% year-on-year

    Cash From Investing

    $8.15M
    PYXS annual cash from investing is $8.15 million

    Cash From Investing 1-Year Change

    +107.78%
    PYXS annual cash from investing is up +107.78% year-on-year

    Cash From Financing

    $59.33M
    PYXS annual cash from financing is $59.33 million

    Cash From Financing 1-Year Change

    +900.61%
    PYXS annual cash from financing is up +900.61% year-on-year

    CAPEX

    CAPEX

    $237.00K
    PYXS annual capital expenditures is $237.00 thousand

    CAPEX 1-Year Change

    -96.48%
    PYXS annual capital expenditures is down -96.48% year-on-year

    Free Cash Flow

    Free Cash Flow

    -$57.91M
    PYXS annual free cash flow is -$57.91 million

    Free Cash Flow 1-Year Change

    +25.22%
    PYXS annual free cash flow is up +25.22% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross Margin

    78.59%
    PYXS annual gross profit margin is 78.59%

    Operating Margin

    -424.23%
    PYXS annual operating profit margin is -424.23%

    Net Margin

    -478.95%
    PYXS annual net profit margin is -478.95%

    ROA & ROE

    ROA

    -46.74%
    PYXS annual return on assets is -46.74%

    ROE

    -62.75%
    PYXS annual return on equity is -62.75%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE Ratio

    -
    PYXS price to earnings ratio value is unknown

    PE Ratio Sector Percentile

    -
    PYXS price to earnings ratio is unknown

    PB Ratio

    PB Ratio

    1.82
    PYXS price to book ratio is 1.82

    PB Ratio Sector Percentile

    48.61%
    PYXS price to book ratio is higher than 48.61% of companies in Healthcare sector

    PS Ratio

    PS Ratio

    56.52
    PYXS price to sales ratio is 56.52

    PS Ratio Sector Percentile

    87.34%
    PYXS price to sales ratio is higher than 87.34% of companies in Healthcare sector

    Enterprise value

    Enterprise Value

    $88.43M
    PYXS enterprise value is $88.43 million

    Enterprise Value Sector Percentile

    44.1%
    PYXS enterprise value is higher than 44.1% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -1.06
    PYXS EV/EBITDA is -1.06

    EV/EBITDA Sector Percentile

    47.7%
    PYXS EV/EBITDA is higher than 47.7% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current Ratio

    7.49
    PYXS annual current ratio is 7.49

    Quick Ratio

    7.49
    PYXS annual quick ratio is 7.49

    Leverage

    Debt To Equity

    0.17
    PYXS annual debt to equity ratio is 0.17

    Interest Coverage Ratio

    -
    PYXS annual interest coverage ratio value is unknown

    Risk & Stability

    F-Score

    -
    PYXS piotroski f-score value is unknown

    Altman Z-Score

    -1.07
    PYXS altman z-score is -1.07

    Analyst ratings

    Recent major analysts updates

    Sep 4, 25 Guggenheim
    Buy
    Aug 19, 25 HC Wainwright & Co.
    Buy
    May 19, 25 HC Wainwright & Co.
    Buy
    Mar 19, 25 RBC Capital
    Outperform
    Mar 19, 25 HC Wainwright & Co.
    Buy
    Dec 20, 24 RBC Capital
    Outperform
    Dec 20, 24 HC Wainwright & Co.
    Buy
    Nov 21, 24 William Blair
    Market Perform
    Nov 21, 24 RBC Capital
    Outperform
    Nov 21, 24 HC Wainwright & Co.
    Buy

    Institutional Ownership

    Screeners with PYXS included

    Growing Shares Outstanding
    US stocks
    Stocks with high beta
    Best performing stocks last month
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    • What is the ticker symbol for Pyxis Oncology, Inc.?
    • Does Pyxis Oncology, Inc. pay dividends?
    • What sector is Pyxis Oncology, Inc. in?
    • What industry is Pyxis Oncology, Inc. in?
    • What country is Pyxis Oncology, Inc. based in?
    • When did Pyxis Oncology, Inc. go public?
    • Is Pyxis Oncology, Inc. in the S&P 500?
    • Is Pyxis Oncology, Inc. in the NASDAQ 100?
    • Is Pyxis Oncology, Inc. in the Dow Jones?
    • When was Pyxis Oncology, Inc.'s last earnings report?
    • When does Pyxis Oncology, Inc. report earnings?

    What is the ticker symbol for Pyxis Oncology, Inc.?

    The ticker symbol for Pyxis Oncology, Inc. is NASDAQ:PYXS

    Does Pyxis Oncology, Inc. pay dividends?

    No, Pyxis Oncology, Inc. does not pay dividends

    What sector is Pyxis Oncology, Inc. in?

    Pyxis Oncology, Inc. is in the Healthcare sector

    What industry is Pyxis Oncology, Inc. in?

    Pyxis Oncology, Inc. is in the Biotechnology industry

    What country is Pyxis Oncology, Inc. based in?

    Pyxis Oncology, Inc. is headquartered in United States

    When did Pyxis Oncology, Inc. go public?

    Pyxis Oncology, Inc.'s initial public offering (IPO) was on October 8, 2021

    Is Pyxis Oncology, Inc. in the S&P 500?

    No, Pyxis Oncology, Inc. is not included in the S&P 500 index

    Is Pyxis Oncology, Inc. in the NASDAQ 100?

    No, Pyxis Oncology, Inc. is not included in the NASDAQ 100 index

    Is Pyxis Oncology, Inc. in the Dow Jones?

    No, Pyxis Oncology, Inc. is not included in the Dow Jones index

    When was Pyxis Oncology, Inc.'s last earnings report?

    Pyxis Oncology, Inc.'s most recent earnings report was on August 14, 2025

    When does Pyxis Oncology, Inc. report earnings?

    The next expected earnings date for Pyxis Oncology, Inc. is November 11, 2025
    On this page